You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relatlimab

Showing 1 - 25 of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma (Skin) Trial in Houston (BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab)

Not yet recruiting
  • Melanoma (Skin)
  • BMS-986213 (Relatlimab-Nivolumab FDC)
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2023

Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)

Not yet recruiting
  • Merkel Cell Carcinoma
  • Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
  • Wollstonecraft, New South Wales, Australia
    Melanoma Institute Australia
Nov 21, 2023

Metastatic Melanoma, Metastasis to Brain Trial in Tampa, Houston (Nivolumab, Ipilimumab, Nivolumab + Relatlimab)

Recruiting
  • Metastatic Melanoma
  • Metastasis to Brain
  • Tampa, Florida
  • +1 more
Jan 30, 2023

Stage II Melanoma Trial in Wollstonecraft (Relatlimab and nivolumab fixed dose combination (FDC))

Not yet recruiting
  • Stage II Melanoma
  • Relatlimab and nivolumab fixed dose combination (FDC)
  • Wollstonecraft, New South Wales, Australia
    Melanoma Institute Australia
Oct 26, 2022

Metastatic Uveal Melanoma Trial in Miami (Nivolumab, Relatlimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center
Aug 23, 2022

Advanced Solid Tumors Trial in Shanghai (Relatlimab, Nivolumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Relatlimab
  • Nivolumab
  • Shanghai, Shanghai, China
    Local Institution
Aug 10, 2022

Melanoma Trial in United States (IO102/IO103, Nivolumab-Relatlimab)

Recruiting
  • Melanoma
  • Basking Ridge, New Jersey
  • +6 more
Jun 23, 2023

Melanoma Trial in Worldwide (relatlimab+nivolumab, relatlimab+nivolumab+rHuPH20, nivolumab)

Not yet recruiting
  • Melanoma
  • Anchorage, Alaska
  • +28 more
Oct 20, 2023

Advanced Solid Tumors Trial in Beijing (BMS-986213)

Recruiting
  • Advanced Solid Tumors
  • Beijing, Beijing, China
  • +1 more
Nov 21, 2022

Advanced Melanoma, Metastatic Melanoma Trial in Saint Louis (Memory-like natural killer cells, Relatilmab, Nivolumab)

Not yet recruiting
  • Advanced Melanoma
  • Metastatic Melanoma
  • Memory-like natural killer cells
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 16, 2022

Microsatellite Stable (MSS) Colorectal Adenocarcinomas, Colorectal Adenocarcinoma Trial in Baltimore (Nivolumab, Relatlimab)

Recruiting
  • Microsatellite Stable (MSS) Colorectal Adenocarcinomas
  • Colorectal Adenocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy, MSI-H Tumors Trial in Baltimore (Nivolumab, Relatlimab)

Recruiting
  • Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy
  • MSI-H Tumors
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Basal Cell Carcinoma Trial in Baltimore (Nivolumab, Ipilimumab, Relatlimab)

Recruiting
  • Basal Cell Carcinoma
  • Baltimore, Maryland
    Johns Hopkins Hospital
Mar 10, 2022

Melanoma, Unresectable Melanoma Trial in Los Angeles, Boston, New York (Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab)

Not yet recruiting
  • Melanoma
  • Unresectable Melanoma
  • Los Angeles, California
  • +3 more
Aug 4, 2022

Hepatocellular Carcinoma Trial in Baltimore (Nivolumab, Relatlimab)

Recruiting
  • Hepatocellular Carcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 3, 2022

Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Pittsburgh (Nivolumab, Relatlimab, Ipilimumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 31, 2022

Soft Tissue Sarcoma Adult, Advanced Cancer Trial in France (Association of Nivolumab + Relatlimab, Nivolumab)

Recruiting
  • Soft Tissue Sarcoma Adult
  • Advanced Cancer
  • Bordeaux, France
  • +4 more
Feb 1, 2022

Uveal Melanoma Trial in San Francisco (stereotactic body radiotherapy, Immunotherapy)

Recruiting
  • Uveal Melanoma
  • San Francisco, California
    California Pacific Medical Center Research Institute
Dec 2, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Pittsburgh (Nivolumab+Relatlimab, Nivolumab+Ipilimumab)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 13, 2022

Nasopharyngeal Carcinoma Trial (procedure, drug, biological)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Sep 12, 2023

Cancer Trial in Hackensack (relatlimab, nivolumab, rHuPH20)

Active, not recruiting
  • Cancer
  • relatlimab
  • +2 more
  • Hackensack, New Jersey
    Hackensack University Medical Center
Sep 13, 2021

Melanoma Trial in Worldwide (Relatlimab, Ipilimumab)

Active, not recruiting
  • Melanoma
  • Tucson, Arizona
  • +29 more
Dec 13, 2022

Carcinomas, Renal Medullary Carcinoma Trial in Houston (Nivolumab, Relatlimab)

Not yet recruiting
  • Carcinomas
  • Renal Medullary Carcinoma
  • Houston, Texas
    MD Anderson Cancer Center
Apr 20, 2022

Acute Myeloid Leukemia Trial in Munich (Azacitidine Injection, Nivolumab, Relatlimab)

Recruiting
  • Acute Myeloid Leukemia
  • Azacitidine Injection
  • +2 more
  • Munich, Germany
    University Hospital, LMU Munich
May 30, 2021

Metastatic Melanoma, Advanced Melanoma, Metastatic Melanoma Stratified by MHC-II Expression Trial in Nashville (Nivolumab,

Terminated
Has Results
  • Metastatic Melanoma
  • +2 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Mar 26, 2021